Penetron Crystalline Technology Supports Long-Term Durability of Slovakia's D1 Hubová-Ivachnová Motorway

Completion of the D1 Hubová–Ivachnová motorway section strengthens a critical northern Slovakia transport corridor, improving road safety, travel times, and regional connectivity. The Penetron System of crystalline concrete waterproofing products was specified to enhance the durability and service life of exposed concrete elements.

ORLANDO, Fla., Oct. 9, 2026 /PRNewswire/ -- The D1 Hubová–Ivachnová motorway section is a major transport infrastructure project in northern Slovakia and a key component of the country's principal east–west motorway corridor. The approximately 14.9-km (9.2-miles) section will create a northern bypass of Ružomberok, a center of Slovakia's paper industry and a popular tourist destination, helping divert transit traffic from the urban area and improve network reliability.

Designed for a technically demanding alignment, the project comprised 19 bridge structures, three interchanges, and the approximately 3.6 km twin-tube Čebrať Tunnel. The route crosses mountainous terrain with complex geological conditions and severe seasonal exposure, placing high demands on concrete durability, waterproofing, and corrosion protection strategies.

"Motorway infrastructure in this region is exposed to demanding environmental conditions throughout the year," says Evgeniy Artukh, Director of Penetron Slovakia. "Concrete elements must withstand repeated moisture exposure, freeze-thaw cycling, and de-icing chemicals, making durable concrete protection essential to long-term infrastructure performance."

To mitigate the effects of harsh environmental exposure, the project's civil engineers specified the Penetron System of crystalline waterproofing technology for the exposed concrete bridge curbs. These components are routinely subjected to water infiltration, freeze-thaw cycles, and chloride attack from de-icing salts, all of which can accelerate concrete degradation and corrosion of reinforcing steel.

Applied directly to the prepared concrete surface as a topical treatment, Penetron's active crystalline technology penetrates the concrete and reacts with moisture and components of the concrete matrix to form insoluble crystals within pores, capillaries, and microcracks. This crystalline network helps reduce concrete permeability and restrict the penetration of water and aggressive chemicals.

"By providing protection from within the concrete structure, the Penetron System helps improve resistance to harsh exposure conditions and supports a longer service life with reduced maintenance requirements," adds Evgeniy Artukh.

The Penetron Group is a leading manufacturer of specialty construction products for concrete waterproofing, concrete repairs, and floor preparation systems. The Group operates through a global network, offering support to the design and construction community through its regional offices, representatives, and distribution channels.

For more information on Penetron waterproofing solutions, please visit penetron(dot)com or Facebook(dot)com/ThePenetronGroup, email CRDept(at)penetron(dot)com or contact the Corporate Relations Department at 631-941-9700.

SOURCE The Penetron Group

Share this article

New agreement incorporates advanced generative AI, security, and infrastructure capabilities to drive technological transformation

SUNNYVALE, Calif. and MADRID, Oct. 9, 2026 /PRNewswire/ -- CaixaBank today announced an expanded strategic agreement with Google Cloud, strengthening its technological capabilities in key areas such as artificial intelligence (AI), data management, data analytics, and cloud infrastructure. Building on an alliance established in 2023, the expanded agreement, which extends the collaboration until 2033, will increase the entity's adoption of AI and cloud technologies, and accelerate the development of tools aimed at improving operational decision-making for its employees while enhancing the personalization of products and services for its millions of customers.

As part of the new agreement, CaixaBank will deploy Gemini Enterprise, Google Cloud's AI platform for building, governing, and deploying agents. These agents will empower CaixaBank's teams to synthesize complex financial information, automate routine tasks, and optimize daily workflows.

To support CaixaBank's strategic goals, the expanded collaboration will focus on three key pillars:

- Data analytics and agentic AI: CaixaBank will turn large data repositories into actionable insights. Using Gemini Enterprise, teams will deploy specialized AI agents to streamline document management, classification, and complex content summarization, accelerating internal decision-making.

- Hybrid infrastructure and security: CaixaBank will pair its private environment with Google Cloud's secure infrastructure to improve system resilience, scalability, and service availability to accommodate future growth. The rollout also adds advanced threat detection and security monitoring under CaixaBank's strict governance and responsible AI frameworks.

- Workforce training and enablement: The program also includes specialized professional services, collaborative initiatives, and training courses to facilitate the adoption of new technological capabilities and team enablement. The work will be carried out under CaixaBank's governance and its security, privacy, and responsible AI frameworks.

Through this expanded alliance, CaixaBank reaffirms its commitment to collaborating with cutting-edge AI and technology partners. By leveraging Google Cloud's advanced AI and data capabilities, the bank is poised to drive the continuous transformation of its business model and define the future of digital banking.

About CaixaBank

Innovation is one of CaixaBank's strategic pillars and a key element in reinforcing its leadership in the financial sector. With the largest digital customer base in Spain's financial industry, exceeding 13 million customers, the bank promotes a vision of innovation based on the combination of technology, expertise and customer proximity. Its goal is to develop new products and services, improve the user experience, increase operational efficiency and create new growth opportunities.

About Google Cloud

Google Cloud offers a powerful, optimized AI stack—including AI infrastructure, leading models like Gemini, data management capabilities, multicloud security solutions, developer tools and platform, as well as agents and applications—that enables organizations to transform their business for the Agentic Era. Customers in more than 200 countries and territories turn to Google Cloud as their trusted technology partner.

SOURCE Google Cloud

Share this article

PHILADELPHIA, Oct. 9, 2026 /PRNewswire/ -- TENA, a global leader in incontinence care, has been named a Proud Partner of the Philadelphia 76ers.

As the Presenting Partner of TENA's "Blocking the Stigma" campaign, TENA will connect with 76ers fans through an integrated awareness initiative that combines in-arena visibility, digital engagement, social activation, and community impact.

Through this campaign, for every block made throughout the season by the 76ers, TENA will donate up to $25,000 worth of incontinence products to a local community organization, helping bring attention to men's health while supporting their wellbeing in the Philadelphia region.

Hazel Villarreal, Marketing Director for TENA North America, says: "We're excited to partner with the Philadelphia 76ers in this new chapter. This partnership gives us a powerful platform to raise awareness and show men that bladder leaks don't have to hold them back. Our hope is to help men experiencing bladder leakage to seek solutions, regain their confidence, and stay engaged in the passions and moments that matter most to them.

"This partnership provides an opportunity to reach men who may be experiencing bladder leakage but have not yet sought solutions or openly discussed the condition. By tapping into the energy of professional basketball, TENA can reach men where they already feel at home, engaged, confident, and comfortable."

Villarreal adds: "This marks an important milestone in TENA's efforts to raise awareness, spark meaningful conversations, and break down stigma around men's health, continuing to normalize the conversation about bladder health while giving men greater awareness of the products available to help them feel comfortable and confident in their day-to-day lives."

Thiago Icassati, Vice President Personal Care for Essity North America says: " Sports are central to our TENA strategy because they celebrate confidence, performance and participation at every stage of life. By partnering in spaces where people are already focused on staying active and pursuing their goals, we can help normalize conversations about bladder weakness and empower more people to live life without limits"

Icassati adds: "1 in 4 men over 40* will experience drips and dribbles in their lifetime. We want them to know we have a solution, our goal is to help them manage the condition with confidence, dignity, and peace of mind."

More information on men's bladder health can be found here.

Sources:

*TENA study conducted in 2025.

About TENA – Essity

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2025, Essity had net sales of approximately $14B and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. Learn more at essityusa.com and connect with us on Facebook, LinkedIn and Instagram.

SOURCE TENA

Share this article

WuXi Biologics at CPHI Milan 2026: Empowering Biomanufacturing in Europe

How quality, supply resilience, manufacturing excellence and innovation are supporting the next generation of biologics.

MILAN, Oct. 9, 2026 /PRNewswire/ -- Europe's biologics sector is expanding as ageing populations and the rising burden of chronic, autoimmune and rare diseases increase demand for advanced therapies. The European biologics market was valued at an estimated US$123.75 billion in 2025 and is projected to grow at a CAGR of 8.1% from 2026 to 2035, reaching approximately US$269.65 billion by 2035, underscoring the need for faster development, dependable manufacturing and resilient regional supply.

That urgency is on display at CPHI Milan 2026, which brings together more than 62,000 pharmaceutical professionals and 2,900 exhibitors. During the event, Wuxi Biologics engaged extensively with global biopharma partners, demonstrating how its innovative technologies can advance complex biologics from development to reliable supply.

As biologics pipelines become more complex and supply resilience grows in importance, biopharmaceutical companies are seeking partners that can combine quality, manufacturing excellence, global reach, speed and innovation. WuXi Biologics brings these capabilities together through its integrated CRDMO platform and strategically positioned operations in Europe.

Superior Quality: Building Confidence from Development to Supply

For biologics clients, quality and execution are closely connected. A strong quality system must be supported by the operational discipline to transfer processes, complete qualification activities and manufacture consistently across programs and sites.

As of June 2026, WuXi Biologics had passed 49 regulatory inspections, including 23 conducted by the FDA and EMA, secured 166 facility license approvals, and passed more than 2,000 GMP quality audits by global clients, including over 280 audits by EU Qualified Persons.

This regulatory and client-audit track record provides an important foundation, but execution is demonstrated through delivery. Integrated MSAT, quality, manufacturing and project teams work together to manage technology transfer, PPQ and ongoing production. Consistent governance and shared technical standards help programs move across development and manufacturing stages with reduced handover risk.

For clients, superior quality and execution provide confidence that a program can progress from a promising molecule to repeatable, compliant and reliable supply.

Global Network: Strengthening Supply Resilience and Agility

Companies are evaluating supplier concentration, single-site dependency, region-for-region strategies and the ability to access alternative manufacturing pathways with quality and technical consistency.

WuXi Biologics operates a global manufacturing network spanning Ireland, Germany, the United States, China and Singapore. Globally unified quality systems, integrated technology platforms and coordinated execution connect these locations as one robust network.

At the center of this approach is Global Dual Sourcing, designed to build supply agility by aligning quality, analytics and technology transfer across global sites. Leveraging proven experience from across the network, integrated technical teams and unified project governance enable manufacturing processes to be transferred, scaled and replicated while maintaining product quality, comparability and execution consistency. This allows customers to evaluate manufacturing pathways according to program requirements, scale, market needs and supply strategy.

Strengthening Manufacturing in Europe

Europe plays a strategic role within this global network. Regional manufacturing options can bring production closer to key markets and regulatory environments, while connection to a broader network provides access to shared platforms, quality systems, technical expertise and supply optionality. WuXi Biologics' operations in Dundalk, Ireland, and Wuppertal, Germany, provide complementary capabilities within this model.

Dundalk, Ireland:

An Established Commercial Manufacturing Hub

Dundalk site is WuXi Biologics' established commercial manufacturing hub in Europe. The site operates under an HPRA GMP manufacturing license, supports EMA-approved commercial products and has served more than 10 clients. It provides 54,000 L of drug-substance manufacturing capacity across perfusion and fed-batch platforms. In 2026, the site secured multiple new large-scale manufacturing projects and initiated the associated technology transfers.

Dundalk site has demonstrated the successful execution of WuXi Biologics' Global Dual Sourcing strategy. Across multiple programs, the site has supported same-scale transfers, scale-up transfers and process-enhancement transfers while maintaining product comparability and consistent quality standards. Successful PPQ execution across sites and support for EMA-approved commercial products further demonstrate the ability to transfer and replicate manufacturing processes within the network while ensuring reliable supply.

The site has also received industry recognition for its operational performance. It received the ISPE Facility of the Year Award in 2023. In 2026, WuXi Biologics Ireland received the Overall Excellence in Life Sciences Award, while its MSAT team was named Life Sciences Team of the Year. Together, these milestones reflect Dundalk's development into a proven commercial manufacturing operation within both the European life-sciences ecosystem and WuXi Biologics' global network.

Wuppertal, Germany:

Expanding Manufacturing Agility

Complementing Dundalk, WuXi Biologics' Wuppertal site offers flexible drug-substance manufacturing at different scales and stages of development, backed by technology transfer, MSAT, quality-control and logistics capabilities across the regional platform. The site currently includes 12,000 L single-use bioreactors capacity, with future expansion potential to 24,000 L. Supporting functions include GMP-certified quality-control laboratories and integrated warehousing capabilities.

Located in North Rhine-Westphalia, one of Europe's leading life-sciences regions, Wuppertal supports clinical, late-stage and commercial programs. Together, Dundalk and Wuppertal provide complementary European capabilities connected by globally aligned technology, quality and execution systems.

Unmatched Speed: Accelerating Progress with Certainty

Reliable manufacturing must be matched by the ability to move programs forward efficiently from development through scale-up and commercial supply. True acceleration comes from combining speed, quality and execution certainty. WuXi Biologics brings together platform technologies, mature technology-transfer infrastructure, integrated CMC expertise and coordinated manufacturing execution to support faster, de-risked progress across the product lifecycle.

As of June 2026, WuXi Biologics supported 1,064 integrated projects, including 221 bispecific and multi-specific antibody projects and 328 ADC projects. Complex modalities represented more than half of the portfolio, giving the company broad experience in translating novel science into scalable processes.

Its integrated CRDMO platform has empowered more than 66 DNA to IND projects within six months, supported by a 100% IND-filing success rate, while its global capacity and platform readiness enable the company to initiate any client project within four weeks. Across WuXi Biologics' manufacturing network, technology transfer to PPQ has been completed in as little as 3.5 months. The company has also maintained a 100% PPQ campaign success rate, with 34 PPQs scheduled for 2026 and another 30 for 2027.

Technology platforms help underpin this execution. WuXia™ TrueSite, the fourth generation of the company's cell-line platform, uses targeted integration to deliver predictable, stable expression. It has achieved 8-12 g/L titers for monoclonal antibodies and 7-10 g/L titers for bispecific antibodies, with more than 99% of clonal cell lines maintaining stable protein expression after 60 generations, and can support an IND-ready CMC timeline within six months.

For high-dose delivery, WuXiHigh™ 2.0 integrates formulation, device and manufacturing development for patient-friendly subcutaneous therapies. The platform supports protein concentrations up to 240 mg/mL and viscosity reductions of up to 90%, while connecting high-throughput formulation work with fill-finish, drug-device combination and large-volume delivery options.

Together, these capabilities demonstrate that sustainable speed is not simply about shortening timelines. It comes from integrating proven platforms, development expertise, technology-transfer experience and manufacturing discipline to move complex programs forward with control and confidence.

Integrated CRDMO Platform: Advancing Complex Biologics to Reliable Supply

The direction of biomanufacturing is clear: supply strategies are becoming more regional and resilient, molecules are becoming more complex, and customers expect reliable execution from development through commercial supply. Meeting those demands requires more than capacity. It requires quality confidence, a connected global network, manufacturing excellence, execution speed and integrated technology.

Through its integrated CRDMO platform and European operations, WuXi Biologics is helping clients turn scientific progress into dependable clinical and commercial supply. Dundalk site provides established commercial manufacturing, while Wuppertal site adds flexibility for clinical, late-stage and commercial programs. Both are part of a broader network designed to combine global scale with regional options.

Infinity Power Taps AIKO for 773.5 MWp South African Solar Portfolio, Extending Africa Partnership Beyond 2 GWp

YIWU, China, Oct. 9, 2026 /PRNewswire/ -- AIKO will supply its high-power ABC (All Back Contact) solar modules for three utility-scale solar projects in South Africa under an agreement with Infinity Power, the largest African pure-play renewable energy provider. The deal marks the partnership's first project in South Africa, and pushes their combined project collaboration across Africa past the 2 GWp milestone.

Under the agreement, AIKO will provide high‑efficiency ABC 1,195,136 modules expected to generate more than 1,871 GWh of annual energy for the 773.5 MWp combined portfolio covering three large‑scale Infinity Power projects — Highveld, Onderstepoort Solar 1 (OS1) and Onderstepoort Solar 2 (OS2). Awarded under Bid Window 7 of South Africa's Renewable Energy Independent Power Producer Procurement Programme (REIPPPP), the projects will operate under planned 20‑year power purchase agreements (PPAs) with Eskom and will be built under two EPC packages — Sterling and Wilson Renewable Energy on Highveld and PowerChina Guizhou Engineering on the OS1 and OS2.

Located in Mpumalanga, South Africa, once operational, the Highveld project will generate clean energy sufficient to power approximately 167,000 homes, while avoiding approximately 660,000 tonnes of CO₂ emissions annually. Onderstepoort Solar 1 and 2 located in the northwest, are expected to power approximately 289,000 homes and avoid more than 1.1 million tonnes of CO₂ emissions annually, bringing the Infinity Power portfolio's total estimated annual CO₂ emissions avoided to approximately 1.7 million tonnes, based on public estimates.

Infinity Power was awarded 1.28 GW in solar capacity during this bidding round, the largest allocation among successful bidders in Bid Window 7. As the largest African pure-play renewable energy provider, the company develops, builds and operates large-scale solar and wind projects across the African continent.

Ahmed Zakaria, Director of EPC and Strategic Procurement at Infinity Power, said: "Our decision to partner with AIKO on our South African portfolio based on their capability to meet our technical requirements and reliable delivery commitment we have witnessed across our projects in Egypt. AIKO's ABC technology delivers the efficiency and execution certainty required to deliver large‑scale projects under the REIPPPP framework, and we look forward to bringing full portfolio into commercial operation."

AIKO's ABC modules, AIKO-A645/650-GRH66Dw, were selected on the strength of both performance and execution. With the REIPPPP launched to tackle South Africa's energy crisis, and tender tariffs falling with each successive round, project economics have become a decisive factor in module selection. The high power output of ABC modules reduces the total module count and balance-of-system (BOS) components such as mounting structures and cabling, lowering overall system costs and keeping projects economically competitive under the auction mechanism. In South Africa's high-irradiance, high-temperature conditions, the modules' superior temperature coefficient maintains more stable power output, lifting energy yield across the project's full lifecycle, with efficiency reaching up to 24.1%. Low degradation rates (≤1% in the first year, and 0.35% annually from years 2 to 30) secure stable generation throughout the 20-year PPA term, enhancing long-term returns and project bankability. Full traceability across module production and delivery, together with a delivery schedule aligned to the two EPC packages, provides further certainty of execution across the three sites.

The agreement marks AIKO's first collaboration with Infinity Power in South Africa and their third overall collaboration in Africa, following the 258.5 MWp Nefer Benban and 1.2 GWp Nefer Menya projects in Egypt. With cumulative cooperation now exceeding 2 GWp, the partnership continues to expand, underscoring a global benchmark developer's sustained confidence in the efficiency and reliability of ABC technology, as well as its recognition of AIKO's supply capabilities and product quality.

About Infinity Power

Infinity Power, a joint venture between Infinity and Masdar, is the largest African pure-play renewable energy provider. Infinity Power targets power generation projects in Africa through renewable energy sources, namely solar and wind, as well as other technologies such as battery storage, aiming for 10 GW of operational capacity by 2032.

The company has a substantial operational portfolio of approximately 1.3 GW across Egypt, South Africa and Senegal, helping to avoid over 3 million tonnes of CO₂ emissions annually, alongside 6.3 GW of wind and solar capacity under development, including 3.8 GW in advanced development. For further information about Infinity Power, visit www.weareinfinitypower.com

About AIKO

AIKO is a top-ranked solar technology leader specializing in the research, development, and manufacturing of solar generation products. The company offers solar cells, ABC (All Back Contact) modules, and scenario-based packaged solutions. Guided by the mission of "Leading Humanity into the Carbon-Free Era," AIKO continues to pursue extreme innovation and cutting-edge technology. For more information, please visit https://aikosolar.com.

Share this article

New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali

Under the Patronage of His Excellency Prabowo Subianto, President of the Republic of Indonesia

JAKARTA, Indonesia, Oct. 9, 2026 /PRNewswire/ -- A new global platform for investment, capital formation and economic partnership will launch 3-4 December in Bali, Indonesia. The New Asia Forum has set a target of US$30 billion in investment into the New Asia at its inaugural edition. The forum will connect long-term capital with the opportunities shaping Asia's next decade.

Powered by Danantara Indonesia (Indonesia's sovereign fund) and produced by Richard Attias & Associates, New Asia Forum is being created with a clear ambition: to become the global gateway to the New Asia, connecting long-term capital with the projects, partnerships and policymakers capable of transforming vision into investment.

The world's economic center of gravity is shifting. A new generation of economies is emerging across the region; increasingly connected, technologically ambitious, investment-driven and capable of financing its own future. Asia-Pacific already generates close to 60% of global economic growth (IMF, 2025). Yet, it attracts far less of its share of long-term international capital. New Asia Forum aims to close that gap.

Unlike traditional conferences, New Asia Forum is designed around transaction readiness, capital deployment and execution. The US$30 billion target will be pursued through a curated pipeline of investment-ready opportunities. Heads of state, ministers, sovereign investors and global CEOs will turn diligence into signed commitments across eight strategic sectors:

1. Strategic Resources and Downstreaming 2. Energy and Power 3. Mobility and Advanced Manufacturing 4. Digital Infrastructure and AI 5. Food and Agribusiness 6. Trade and Connectivity 7. Tourism and Creative Economy 8. Education and Human Capital

New Asia Forum will track commitments and progress across editions, creating an ongoing platform of accountability, partnership and investment.

Rosan Roeslani, Chief Executive Officer of Danantara Indonesia and Minister of Investment to the Republic of Indonesia, said, "New Asia Forum brings long-term global capital closer to the opportunities being created across Indonesia and the wider region. As Indonesia's sovereign investor and a founding partner of the Forum, Danantara Indonesia is inviting partners together to unlock these opportunities for long-term value. Under the patronage of President Prabowo Subianto, this is Indonesia engaging the world from a position of confidence, ambition, and collaboration."

"For decades, Asia has been viewed primarily as a destination for global capital. That story is changing," said Richard Attias, Founder and Chairman of Richard Attias & Associates. "The New Asia will not simply attract capital. It will increasingly create it, direct it and determine where it can have the greatest impact. We are entering one of the most important investment cycles of our generation, and Asia is at its center."

The inaugural New Asia Forum will be an invitation-only gathering of more than 1,000 leaders, featuring over 100 speakers and over 40 sessions across two days.

Share this article

Chelsea FC announces new global partnership with GAC

GUANGZHOU, China and LONDON, Oct. 9, 2026 /PRNewswire/ -- Chelsea Football Club today announced a global partnership, with GAC – one of the world's fastest growing global automotive businesses – which sees them become the club's Official Automotive Partner. The partnership brings together Chelsea's global football community and GAC's growing global automotive business, creating closer connections with fans and consumers in the UK, across Europe and beyond.

Chelsea FC has one of the largest global fan bases in the world with millions of supporters across Europe and beyond. GAC are one of China's largest automobile manufacturers and the partnership comes at a time when GAC is expanding its global reach and into new markets with its range of high-quality, practical models.

GAC and Chelsea FC first joined forces for the 2026 pre-season tour and this new chapter together will see vehicles from GAC's AION range escorting the men's team to Stamford Bridge on selected matchdays. GAC and Chelsea FC will also collaborate on digital storytelling, fan experiences and engagement including car displays, providing opportunities for the Chelsea family to discover GAC and its vehicles.

The UK and Europe are important markets in GAC's international development. The partnership with Chelsea FC adds a new dimension to this work, complementing product introductions, sales-channel development and customer support. It will help GAC reach audiences beyond traditional automotive channels as the company continues to build its presence across the region.

GAC's European lineup includes the AION V electric SUV and the AION UT compact electric hatchback, offering options for family travel and everyday mobility. Both models reflect the company's focus on practical usability, technology and quality.

The partnership also forms part of GAC's One GAC 2.0 global strategy and its Local for Local approach. By combining the partnership's international reach with activities shaped around local interests, GAC and Chelsea FC will build lasting connections together with supporters and customers.

Share this article

National No. 24 ranking recognizes Marketing Maven in O'Dwyer's national crisis communications specialty category based on 2025 net fees

LOS ANGELES, Oct. 9, 2026 /PRNewswire/ -- Marketing Maven, a top crisis communications firm and integrated marketing agency, has been ranked No. 24 in O'Dwyer's 2026 Crisis Communications rankings.

The recognition places Marketing Maven among the Top 25 public relations firms in the crisis communications category. O'Dwyer's ranks firms by specialty based on net fee income from public relations counseling and media contact services.

"During a crisis, organizations must communicate quickly while making sure the information they are sharing is accurate and clear," said Lindsey Carnett, CEO and President of Marketing Maven. "Being ranked among O'Dwyer's Top 25 PR firms for crisis communications recognizes the work our team does to help clients navigate situations where preparation, strategy and timely execution are paramount to achieving a successful outcome."

Crisis communications requires organizations to respond to rapidly developing situations while maintaining clear and accurate communication. Marketing Maven includes crisis communications among its public relations services, helping clients prepare for and respond to situations that may require timely communication with the media, statements via social media channels and other audiences.

For more information about Marketing Maven's crisis communications services, including a crisis risk assessment, email [email protected].

About Marketing Maven:

With offices in Los Angeles and New York, Marketing Maven is a full-service marketing and communications agency. With origins in direct response public relations, Marketing Maven has developed into a premier voice in brand strategy, social media, innovative media relations, crisis communications, market research, Hispanic marketing, digital advertising and search engine optimization (SEO/GEO). Marketing Maven leads the industry in utilizing advanced metrics to measure their clients' marketing reach and providing competitive analysis unparalleled in the industry. For additional information about Marketing Maven, visit http://www.MarketingMaven.com.

Press Contact:

Name: Frank Tortorici

Email: [email protected]

SOURCE Marketing Maven Public Relations, Inc.

Share this article

EQT AB's Nomination Committee for the Annual Shareholders' Meeting 2027

STOCKHOLM, Oct. 9, 2026 /PRNewswire/ -- EQT AB's Nomination Committee for the Annual Shareholders' Meeting 2027 has been appointed based on the ownership structure as of 31 August 2026.

The Nomination Committee consists of

- Jacob Wallenberg (Chair), appointed by Investor AB

- Conni Jonsson, appointed by Jean Eric Salata

- Jeremy Coller, appointed by himself

- Joachim Spetz, appointed by Swedbank Robur Funds

- Jean Eric Salata, Chair of the EQT AB Board

As of 31 August 2026, shareholders having appointed members to the Nomination Committee together represented approximately 30 percent of the voting rights for all shares in EQT AB.

Shareholders who would like to submit proposals to the Nomination Committee can do so by e-mail to [email protected], or by ordinary mail under the address: EQT AB, Attn: Nomination Committee, Box 164 09, SE-103 27 Stockholm, Sweden.

Contact

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15

EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com.

The following files are available for download:

Share this article

Skanska to provide railroad improvements in northeast USA for USD 136M, about SEK 1.3 billion

STOCKHOLM, Oct. 9, 2026 /PRNewswire/ -- Skanska has signed a contract with a public client for a railroad improvement project in northeast USA. The contract is worth USD 136M, about SEK 1.3 billion, which will be included in the US order bookings for the third quarter of 2026.

Work has begun and the project is expected to be completed in December 2029.

For further information please contact:

Maritza Ferreira, Vice President of Communications, Skanska USA, tel +1 (678) 492 2003

Andreas Joons, Press Officer, Skanska AB, tel +46 76 870 75 51

Direct line for media, tel +46 (0)10 448 88 99

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

SOURCE Skanska

Share this article